The stocks of TRI have been presented with a rating of buy by close to ten research equities that were covering the firm. According to a report, one of the investment analysts has given the company a rating of sell, while three others have provided the company with a rating of hold. The price target set on the company over a period as set by brokerages is $109.78.
The Stock Commentary Of TRI
There have been quite a few research equities that have commented on the stocks of TRI. The Goldman Sachs Group has already put up a rating of neutral with a price target of $88 in a 17th February research note. BMO Capital Markets has also increased the price target of $127 with a rating of “outperform” in a 24th February research report.
The National Bank Financial has also increased the rating to outperform with a price target of $115 in a 15th January research note. The Royal Bank of Canada has put up a price target of $100 with a rating of “outperform” in a 3rd May research note.
The stocks of TRI traded on Monday at $97.20. The year low of the company is $64.47, with the year high set at $99.14. The current ratio of the company is 1.51, with a 1.51 quick ratio. The market cap of the company is $48.17 billion, with a 25.85 PE ratio, along with a 3.15 PEG ratio. The moving average price of the company over a period of 50 days is $90.82, and the moving average price of the company over a period of 200 days is $84.48.
TRI previously updated its quarterly results on the 4th of May. The EPS reported by the company during this period was $0.58, with the consensus estimate of $0.42.
